about
Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHTransient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice.Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp.Homeostasis of IL-15 dependent lymphocyte subsets in the liver.Non-alcoholic fatty liver disease-From the cardiologist perspective.Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver diseaseProbiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.Role of folate in nonalcoholic fatty liver disease.Alternative RNA Splicing in the Pathogenesis of Liver Disease.Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats.Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice.Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq.Identification of genetic elements in metabolism by high-throughput mouse phenotyping.A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels.Direct effects of thyroid hormones on hepatic lipid metabolism.Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physiciansA nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis
P2860
Q26778376-58C9F641-1A6A-4ED3-8D88-6161F778948AQ28079445-29C03789-AEF1-41F2-970E-262776CF8398Q31134971-DE1060BC-1903-4804-B392-E210F1EBDF46Q36905761-1E36F08C-D547-4D00-A9DE-998D9C733500Q37063273-80083D23-6BFD-4332-ABBC-DA79EBF4AC0AQ37588703-8F67AD76-35E3-47F3-AC2D-156D81E7DEDBQ37626290-F82D216B-C204-4B68-BAFC-0CD7C93A6A69Q37672952-57C73AEC-44EC-4BAE-B1EA-67BA9F868502Q37714347-0D74CF41-F1BB-4E4F-9C1C-2E9E5007B8E2Q37723991-B486B6AD-82AB-404A-9DEF-F945F789F684Q39275518-6E0DDA88-B312-4E1B-86D0-7FD7341537CAQ39416487-E0E33989-AEF7-40E0-B3EC-37521D446A36Q40979075-2FC1620C-4D5C-4748-95A9-C179CFD6AFB4Q41449920-119A1A44-7C96-47AD-840A-FA9343394DA5Q42103025-13E35F0A-13FA-4FAA-B6E7-FBAE7FD53EF8Q42330055-3428137B-A453-4D6D-AEE3-55B9D1130A89Q42730581-CA06C53A-BE73-498E-BFF1-239F35C667F7Q46268603-674AA5BC-1A00-4C88-95E3-F399C2545CC0Q47168303-EF73789B-DEA3-4F7E-863F-98D6CA4270F8Q47175346-7A41239D-40D4-4ACE-A71B-0F02F323831DQ47643645-B77DDBB0-5C38-4AB0-A5E2-A0F53161344CQ55415785-3ABA0184-9EE8-4F2B-A228-85C348253D1BQ55443852-566CA432-1A0A-42C0-81F1-D2FEAE404791Q55709012-132B869F-1ACE-476D-A073-D1EF2AB8F8FDQ57114860-11CBD347-7EF2-49D6-AC41-0E9D963335F9Q57492312-655F5D91-DBBA-49F8-84AD-1A0BEB617E95Q58697388-7255E2C6-4FC2-4C1A-BF50-2830EECD2B96
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-alcoholic fatty liver disease in 2015.
@ast
Non-alcoholic fatty liver disease in 2015.
@en
type
label
Non-alcoholic fatty liver disease in 2015.
@ast
Non-alcoholic fatty liver disease in 2015.
@en
prefLabel
Non-alcoholic fatty liver disease in 2015.
@ast
Non-alcoholic fatty liver disease in 2015.
@en
P2860
P356
P1476
Non-alcoholic fatty liver disease in 2015.
@en
P2093
Monjur Ahmed
P2860
P304
P356
10.4254/WJH.V7.I11.1450
P577
2015-06-01T00:00:00Z